UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

The evolution of poxvirus vaccines

Viruses, 2015-04, Vol.7 (4), p.1726-1803

2015

Volltextzugriff (PDF)

Plasma ACE2 species are differentially altered in COVID‐19 patients

The FASEB journal, 2021-08, Vol.35 (8), p.n/a

2021

Volltextzugriff (PDF)

Plasma ACE2 species are differentially altered in COVID‐19 patients

The FASEB journal, 2021-08, Vol.35 (8), p.e21745-e21745

2021

Volltextzugriff (PDF)

Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome

Journal of proteome research, 2022-01, Vol.21 (1), p.164-171

2022

Volltextzugriff (PDF)

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy

Frontiers in immunology, 2022-10, Vol.13, p.1001951-1001951

2022

Volltextzugriff (PDF)

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways

PloS one, 2013-06, Vol.8 (6), p.e66894

2013

Volltextzugriff (PDF)

Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells

Journal of proteome research, 2019-03, Vol.18 (3), p.900-911

2019

Volltextzugriff (PDF)

Deletion of the Vaccinia Virus N2L Gene Encoding an Inhibitor of IRF3 Improves the Immunogenicity of Modified Vaccinia Virus Ankara Expressing HIV-1 Antigens

Journal of Virology, 2014-03, Vol.88 (6), p.3392-3410

2014

Volltextzugriff (PDF)

Evolutionary Transition toward Defective RNAs That Are Infectious by Complementation

Journal of Virology, 2004-11, Vol.78 (21), p.11678-11685

2004

Volltextzugriff (PDF)

Exploration of sequence space as the basis of viral RNA genome segmentation

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (18), p.6678-6683

2014

Volltextzugriff (PDF)

Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions

PloS one, 2010-08, Vol.5 (8), p.e12395

2010

Volltextzugriff (PDF)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus

Biomedicines, 2021-08, Vol.9 (9), p.1122

2021

Volltextzugriff (PDF)

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence

PLoS neglected tropical diseases, 2019-07, Vol.13 (7), p.e0007547

2019

Volltextzugriff (PDF)

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.354

2022

Volltextzugriff (PDF)

Poxvirus vectors as HIV/AIDS vaccines in humans

Human vaccines & immunotherapeutics, 2012-09, Vol.8 (9), p.1192-1207

2012

Volltextzugriff (PDF)

Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens

PloS one, 2010-06, Vol.5 (6), p.e11406-e11406

2010

Volltextzugriff (PDF)

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Journal of virology, 2021-03, Vol.95 (7)

2021

Volltextzugriff (PDF)

Complex antigen presentation pathway for an HLA-A0201-restricted epitope from Chikungunya 6K protein

PLoS neglected tropical diseases, 2017-10, Vol.11 (10), p.e0006036-e0006036

2017

Volltextzugriff (PDF)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses

Emerging microbes & infections, 2021-01, Vol.10 (1), p.1441-1456

2021

Volltextzugriff (PDF)

Eeyarestatin I, an inhibitor of the valosin-containing protein, exhibits potent virucidal activity against the flaviviruses

Antiviral research, 2022-11, Vol.207, p.105416-105416, Article 105416

2022

Volltextzugriff (PDF)

Enhancing poxvirus vectors vaccine immunogenicity

Human vaccines & immunotherapeutics, 2014-08, Vol.10 (8), p.2235-2244

2014

Volltextzugriff (PDF)

Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized With DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

Vaccines (Basel), 2020-03, Vol.8 (1), p.127

2020

Volltextzugriff (PDF)

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases

Journal of molecular biology, 2023-08, Vol.435 (15), p.168173-168173, Article 168173

2023

Volltextzugriff (PDF)

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

Journal of virology, 2018-06, Vol.92 (11)

2018

Volltextzugriff (PDF)

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

Antiviral research, 2023-12, Vol.220, p.105760-105760, Article 105760

2023

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(87)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(58)
Animals
(41)
Humans
(37)
Vaccines
(31)
Immunology
(28)
Mice
(28)
Virology
(26)
Immunogenicity
(21)
Human Immunodeficiency Virus
(20)
Vaccinia Virus - Genetics
(20)
Poxvirus
(18)
Antigens
(17)
Viruses
(17)
Aids Vaccines - Immunology
(16)
Cd8-Positive T-Lymphocytes - Immunology
(16)
Hiv
(16)
Immune Response
(16)
Genetic Vectors
(15)
Sars-Cov-2
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The evolution of poxvirus vaccines

Plasma ACE2 species are differentially altered in COVID‐19 patients

Plasma ACE2 species are differentially altered in COVID‐19 patients

Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways

Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells

Deletion of the Vaccinia Virus N2L Gene Encoding an Inhibitor of IRF3 Improves the Immunogenicity of Modified Vaccinia Virus Ankara Expressing HIV-1 Antigens

Evolutionary Transition toward Defective RNAs That Are Infectious by Complementation

Exploration of sequence space as the basis of viral RNA genome segmentation

Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara

Poxvirus vectors as HIV/AIDS vaccines in humans

Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Complex antigen presentation pathway for an HLA-A0201-restricted epitope from Chikungunya 6K protein

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses

Eeyarestatin I, an inhibitor of the valosin-containing protein, exhibits potent virucidal activity against the flaviviruses

Enhancing poxvirus vectors vaccine immunogenicity

Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized With DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

Suchergebnisse filtern